type vi collagen Search Results


93
SouthernBiotech goat anti type vi collagen
Goat Anti Type Vi Collagen, supplied by SouthernBiotech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/type+vi+collagen/Goat+Anti-Type+VI+Collagen-BIOT/pm29656108-131-12-18
Average 93 stars, based on 1 article reviews
goat anti type vi collagen - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

94
Biosynth Carbosynth type vi collagen
Figure 1. The expression of <t>Type</t> VI <t>collagen</t> in oral tissues. (A) H&E staining of mandibles from 3-month-old mice. Dashed line shows periodontal ligament. (B) Representative immunofluorescent staining image of Type VI collagen in mouse mandibles of 3-month-old mice (n = 3). Magnified images of boxed areas in panel B are shown in (a’,b’,c’,d’). Nuclei were stained with DAPI (blue). Type VI collagen expression (red) in the periodontal ligament (PDL) (yellow arrowheads), bone marrow (BM) (green arrowheads), gingiva (Gn (blue arrowheads). (C) The abundance of alpha chains of Type VI collagen in murine alveolar bone from 6-week-old mice. M: molar, <t>AB:</t> alveolar bone, DP: dental pulp, Gn: gingiva, BM: bone marrow, PDL: periodontal ligament, Ep: epithelium, CT: connective tissue. Scale bars: (A,B): 500 µm, (a’–d’): 50 µm.
Type Vi Collagen, supplied by Biosynth Carbosynth, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/type+vi+collagen/Collagen+Type+VI+antibody/pm36430826-150-4-7
Average 94 stars, based on 1 article reviews
type vi collagen - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

93
Rockland Immunochemicals human collagen type vi
(A) Confocal microscopic image from “sandwich cultures” shows layered cells expressing either GPR133 (green) or PTK7 (red). Top view from a central confocal slice (center panel: x and y dimension) and orthogonal views (upper panel: z and x; right panel: z and y) depicted on the same scale. Scale bars, 10 μM. (B) HTRF assays in “sandwich cultures” demonstrate that PTK7 in neighboring cells increased cAMP levels in cells expressing <t>wild-type</t> (WT) cleaved GPR133, but not the uncleavable H543R mutant. A secreted PTK7 with no transmembrane domain (no TM, aa 1–703) did not influence GPR133 signaling. Two-way ANOVA: middle layer F 2, 96 = 4.62, not significant; outer layer F 2, 96 = 3.93, not significant; interaction of inner and outer layer F 4, 96 = 7.29, p < 0.0001. Tukey’s multiple comparisons: GPR133-WT-expressing cells with empty vector vs. PTK7 co-culture, p < 0.0001; GPR133-WT-expressing cells with full-length PTK7 vs. secreted PTK7 (no TM) co-culture, p < 0.0001. All other comparisons not significant; n = 4–22 independent experiments. (C) Pre-coating wells with PTK7 NTF (aa 1–703) significantly increased cAMP levels in WT GPR133-expressing, but not H543R uncleavable mutant-expressing cells. COL6 (native purified <t>human</t> <t>collagen</t> VI) had no effect on signaling. Two-way ANOVA: GPR133 variant expressed F 2, 80 = 11.65, p < 0.0001; protein coating F 2, 80 = 12.90, p < 0.0001; interaction of factors F 4, 80 = 9.24, p < 0.0001. Tukey’s multiple comparisons: GPR133-WT-expressing cells on PTK7 NTF-coated vs. uncoated dishes, p < 0.0001; GPR133-WT-expressing cells on PTK7 NTF-coated vs. COL6-coated dishes, p < 0.0001). All other comparisons not significant; n = 5–15 independent experiments. (D) Combinatorial effect of PTK7 binding and p13 Stachel peptide treatment on GPR133 signaling. HEK293T cells expressing either WT GPR133 or empty vector control were seeded onto PTK7 NTF-coated (1.17 μg/cm 2 ) or control-coated wells. Cells were then treated with synthetic p13 Stachel peptide (500 μM), inactive control peptide (500 μM), or solvent controls, and cAMP levels were measured by HTRF. The combination of PTK7 NTF binding and Stachel peptide elicited an additive response in GPR133 signaling compared with the individual treatments. Two-way ANOVA, GPR133 expression effect F 1, 48 = 365.1, p < 0.0001; treatment effect F 7, 48 = 13.2, p < 0.0001; interaction of GPR133 expression and treatment F 7, 48 = 13.2, p < 0.0001. Tukey’s multiple comparisons: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. n = 4 independent experiments. Data are depicted as mean ± SEM. See also and .
Human Collagen Type Vi, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/type+vi+collagen/Human+collagen+type+VI/pmc10445595-16-0-5
Average 93 stars, based on 1 article reviews
human collagen type vi - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

94
Proteintech col4
(A) Confocal microscopic image from “sandwich cultures” shows layered cells expressing either GPR133 (green) or PTK7 (red). Top view from a central confocal slice (center panel: x and y dimension) and orthogonal views (upper panel: z and x; right panel: z and y) depicted on the same scale. Scale bars, 10 μM. (B) HTRF assays in “sandwich cultures” demonstrate that PTK7 in neighboring cells increased cAMP levels in cells expressing <t>wild-type</t> (WT) cleaved GPR133, but not the uncleavable H543R mutant. A secreted PTK7 with no transmembrane domain (no TM, aa 1–703) did not influence GPR133 signaling. Two-way ANOVA: middle layer F 2, 96 = 4.62, not significant; outer layer F 2, 96 = 3.93, not significant; interaction of inner and outer layer F 4, 96 = 7.29, p < 0.0001. Tukey’s multiple comparisons: GPR133-WT-expressing cells with empty vector vs. PTK7 co-culture, p < 0.0001; GPR133-WT-expressing cells with full-length PTK7 vs. secreted PTK7 (no TM) co-culture, p < 0.0001. All other comparisons not significant; n = 4–22 independent experiments. (C) Pre-coating wells with PTK7 NTF (aa 1–703) significantly increased cAMP levels in WT GPR133-expressing, but not H543R uncleavable mutant-expressing cells. COL6 (native purified <t>human</t> <t>collagen</t> VI) had no effect on signaling. Two-way ANOVA: GPR133 variant expressed F 2, 80 = 11.65, p < 0.0001; protein coating F 2, 80 = 12.90, p < 0.0001; interaction of factors F 4, 80 = 9.24, p < 0.0001. Tukey’s multiple comparisons: GPR133-WT-expressing cells on PTK7 NTF-coated vs. uncoated dishes, p < 0.0001; GPR133-WT-expressing cells on PTK7 NTF-coated vs. COL6-coated dishes, p < 0.0001). All other comparisons not significant; n = 5–15 independent experiments. (D) Combinatorial effect of PTK7 binding and p13 Stachel peptide treatment on GPR133 signaling. HEK293T cells expressing either WT GPR133 or empty vector control were seeded onto PTK7 NTF-coated (1.17 μg/cm 2 ) or control-coated wells. Cells were then treated with synthetic p13 Stachel peptide (500 μM), inactive control peptide (500 μM), or solvent controls, and cAMP levels were measured by HTRF. The combination of PTK7 NTF binding and Stachel peptide elicited an additive response in GPR133 signaling compared with the individual treatments. Two-way ANOVA, GPR133 expression effect F 1, 48 = 365.1, p < 0.0001; treatment effect F 7, 48 = 13.2, p < 0.0001; interaction of GPR133 expression and treatment F 7, 48 = 13.2, p < 0.0001. Tukey’s multiple comparisons: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. n = 4 independent experiments. Data are depicted as mean ± SEM. See also and .
Col4, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/type+vi+collagen/Collagen+Type+VI+Antibody/pmc11223343-98-30-63
Average 94 stars, based on 1 article reviews
col4 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

88
Rockland Immunochemicals polyclonal rabbit anti collagen type vi
(A) Confocal microscopic image from “sandwich cultures” shows layered cells expressing either GPR133 (green) or PTK7 (red). Top view from a central confocal slice (center panel: x and y dimension) and orthogonal views (upper panel: z and x; right panel: z and y) depicted on the same scale. Scale bars, 10 μM. (B) HTRF assays in “sandwich cultures” demonstrate that PTK7 in neighboring cells increased cAMP levels in cells expressing <t>wild-type</t> (WT) cleaved GPR133, but not the uncleavable H543R mutant. A secreted PTK7 with no transmembrane domain (no TM, aa 1–703) did not influence GPR133 signaling. Two-way ANOVA: middle layer F 2, 96 = 4.62, not significant; outer layer F 2, 96 = 3.93, not significant; interaction of inner and outer layer F 4, 96 = 7.29, p < 0.0001. Tukey’s multiple comparisons: GPR133-WT-expressing cells with empty vector vs. PTK7 co-culture, p < 0.0001; GPR133-WT-expressing cells with full-length PTK7 vs. secreted PTK7 (no TM) co-culture, p < 0.0001. All other comparisons not significant; n = 4–22 independent experiments. (C) Pre-coating wells with PTK7 NTF (aa 1–703) significantly increased cAMP levels in WT GPR133-expressing, but not H543R uncleavable mutant-expressing cells. COL6 (native purified <t>human</t> <t>collagen</t> VI) had no effect on signaling. Two-way ANOVA: GPR133 variant expressed F 2, 80 = 11.65, p < 0.0001; protein coating F 2, 80 = 12.90, p < 0.0001; interaction of factors F 4, 80 = 9.24, p < 0.0001. Tukey’s multiple comparisons: GPR133-WT-expressing cells on PTK7 NTF-coated vs. uncoated dishes, p < 0.0001; GPR133-WT-expressing cells on PTK7 NTF-coated vs. COL6-coated dishes, p < 0.0001). All other comparisons not significant; n = 5–15 independent experiments. (D) Combinatorial effect of PTK7 binding and p13 Stachel peptide treatment on GPR133 signaling. HEK293T cells expressing either WT GPR133 or empty vector control were seeded onto PTK7 NTF-coated (1.17 μg/cm 2 ) or control-coated wells. Cells were then treated with synthetic p13 Stachel peptide (500 μM), inactive control peptide (500 μM), or solvent controls, and cAMP levels were measured by HTRF. The combination of PTK7 NTF binding and Stachel peptide elicited an additive response in GPR133 signaling compared with the individual treatments. Two-way ANOVA, GPR133 expression effect F 1, 48 = 365.1, p < 0.0001; treatment effect F 7, 48 = 13.2, p < 0.0001; interaction of GPR133 expression and treatment F 7, 48 = 13.2, p < 0.0001. Tukey’s multiple comparisons: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. n = 4 independent experiments. Data are depicted as mean ± SEM. See also and .
Polyclonal Rabbit Anti Collagen Type Vi, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/type+vi+collagen/Collagen+Type+VI+Antibody+Peroxidase+Conjugated/10__1074_slash_jbc__m109__038190-68-17-22
Average 88 stars, based on 1 article reviews
polyclonal rabbit anti collagen type vi - by Bioz Stars, 2026-09
88/100 stars
  Buy from Supplier

92
Rockland Immunochemicals anti collagen vi
(A) Confocal microscopic image from “sandwich cultures” shows layered cells expressing either GPR133 (green) or PTK7 (red). Top view from a central confocal slice (center panel: x and y dimension) and orthogonal views (upper panel: z and x; right panel: z and y) depicted on the same scale. Scale bars, 10 μM. (B) HTRF assays in “sandwich cultures” demonstrate that PTK7 in neighboring cells increased cAMP levels in cells expressing <t>wild-type</t> (WT) cleaved GPR133, but not the uncleavable H543R mutant. A secreted PTK7 with no transmembrane domain (no TM, aa 1–703) did not influence GPR133 signaling. Two-way ANOVA: middle layer F 2, 96 = 4.62, not significant; outer layer F 2, 96 = 3.93, not significant; interaction of inner and outer layer F 4, 96 = 7.29, p < 0.0001. Tukey’s multiple comparisons: GPR133-WT-expressing cells with empty vector vs. PTK7 co-culture, p < 0.0001; GPR133-WT-expressing cells with full-length PTK7 vs. secreted PTK7 (no TM) co-culture, p < 0.0001. All other comparisons not significant; n = 4–22 independent experiments. (C) Pre-coating wells with PTK7 NTF (aa 1–703) significantly increased cAMP levels in WT GPR133-expressing, but not H543R uncleavable mutant-expressing cells. COL6 (native purified <t>human</t> <t>collagen</t> VI) had no effect on signaling. Two-way ANOVA: GPR133 variant expressed F 2, 80 = 11.65, p < 0.0001; protein coating F 2, 80 = 12.90, p < 0.0001; interaction of factors F 4, 80 = 9.24, p < 0.0001. Tukey’s multiple comparisons: GPR133-WT-expressing cells on PTK7 NTF-coated vs. uncoated dishes, p < 0.0001; GPR133-WT-expressing cells on PTK7 NTF-coated vs. COL6-coated dishes, p < 0.0001). All other comparisons not significant; n = 5–15 independent experiments. (D) Combinatorial effect of PTK7 binding and p13 Stachel peptide treatment on GPR133 signaling. HEK293T cells expressing either WT GPR133 or empty vector control were seeded onto PTK7 NTF-coated (1.17 μg/cm 2 ) or control-coated wells. Cells were then treated with synthetic p13 Stachel peptide (500 μM), inactive control peptide (500 μM), or solvent controls, and cAMP levels were measured by HTRF. The combination of PTK7 NTF binding and Stachel peptide elicited an additive response in GPR133 signaling compared with the individual treatments. Two-way ANOVA, GPR133 expression effect F 1, 48 = 365.1, p < 0.0001; treatment effect F 7, 48 = 13.2, p < 0.0001; interaction of GPR133 expression and treatment F 7, 48 = 13.2, p < 0.0001. Tukey’s multiple comparisons: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. n = 4 independent experiments. Data are depicted as mean ± SEM. See also and .
Anti Collagen Vi, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/type+vi+collagen/Collagen+Type+VI+Antibody+Fluorescein+Conjugated/pmc03313673-129-43-45
Average 92 stars, based on 1 article reviews
anti collagen vi - by Bioz Stars, 2026-09
92/100 stars
  Buy from Supplier

91
Biosynth Carbosynth affinity purified rabbit polyclonal collagen type vi antibody
(A) Confocal microscopic image from “sandwich cultures” shows layered cells expressing either GPR133 (green) or PTK7 (red). Top view from a central confocal slice (center panel: x and y dimension) and orthogonal views (upper panel: z and x; right panel: z and y) depicted on the same scale. Scale bars, 10 μM. (B) HTRF assays in “sandwich cultures” demonstrate that PTK7 in neighboring cells increased cAMP levels in cells expressing <t>wild-type</t> (WT) cleaved GPR133, but not the uncleavable H543R mutant. A secreted PTK7 with no transmembrane domain (no TM, aa 1–703) did not influence GPR133 signaling. Two-way ANOVA: middle layer F 2, 96 = 4.62, not significant; outer layer F 2, 96 = 3.93, not significant; interaction of inner and outer layer F 4, 96 = 7.29, p < 0.0001. Tukey’s multiple comparisons: GPR133-WT-expressing cells with empty vector vs. PTK7 co-culture, p < 0.0001; GPR133-WT-expressing cells with full-length PTK7 vs. secreted PTK7 (no TM) co-culture, p < 0.0001. All other comparisons not significant; n = 4–22 independent experiments. (C) Pre-coating wells with PTK7 NTF (aa 1–703) significantly increased cAMP levels in WT GPR133-expressing, but not H543R uncleavable mutant-expressing cells. COL6 (native purified <t>human</t> <t>collagen</t> VI) had no effect on signaling. Two-way ANOVA: GPR133 variant expressed F 2, 80 = 11.65, p < 0.0001; protein coating F 2, 80 = 12.90, p < 0.0001; interaction of factors F 4, 80 = 9.24, p < 0.0001. Tukey’s multiple comparisons: GPR133-WT-expressing cells on PTK7 NTF-coated vs. uncoated dishes, p < 0.0001; GPR133-WT-expressing cells on PTK7 NTF-coated vs. COL6-coated dishes, p < 0.0001). All other comparisons not significant; n = 5–15 independent experiments. (D) Combinatorial effect of PTK7 binding and p13 Stachel peptide treatment on GPR133 signaling. HEK293T cells expressing either WT GPR133 or empty vector control were seeded onto PTK7 NTF-coated (1.17 μg/cm 2 ) or control-coated wells. Cells were then treated with synthetic p13 Stachel peptide (500 μM), inactive control peptide (500 μM), or solvent controls, and cAMP levels were measured by HTRF. The combination of PTK7 NTF binding and Stachel peptide elicited an additive response in GPR133 signaling compared with the individual treatments. Two-way ANOVA, GPR133 expression effect F 1, 48 = 365.1, p < 0.0001; treatment effect F 7, 48 = 13.2, p < 0.0001; interaction of GPR133 expression and treatment F 7, 48 = 13.2, p < 0.0001. Tukey’s multiple comparisons: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. n = 4 independent experiments. Data are depicted as mean ± SEM. See also and .
Affinity Purified Rabbit Polyclonal Collagen Type Vi Antibody, supplied by Biosynth Carbosynth, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/type+vi+collagen/Collagen+Type+VI+antibody/pm36653852-213-8-16
Average 91 stars, based on 1 article reviews
affinity purified rabbit polyclonal collagen type vi antibody - by Bioz Stars, 2026-09
91/100 stars
  Buy from Supplier

91
Rockland Immunochemicals anti collagen vi antibody
(A) Confocal microscopic image from “sandwich cultures” shows layered cells expressing either GPR133 (green) or PTK7 (red). Top view from a central confocal slice (center panel: x and y dimension) and orthogonal views (upper panel: z and x; right panel: z and y) depicted on the same scale. Scale bars, 10 μM. (B) HTRF assays in “sandwich cultures” demonstrate that PTK7 in neighboring cells increased cAMP levels in cells expressing <t>wild-type</t> (WT) cleaved GPR133, but not the uncleavable H543R mutant. A secreted PTK7 with no transmembrane domain (no TM, aa 1–703) did not influence GPR133 signaling. Two-way ANOVA: middle layer F 2, 96 = 4.62, not significant; outer layer F 2, 96 = 3.93, not significant; interaction of inner and outer layer F 4, 96 = 7.29, p < 0.0001. Tukey’s multiple comparisons: GPR133-WT-expressing cells with empty vector vs. PTK7 co-culture, p < 0.0001; GPR133-WT-expressing cells with full-length PTK7 vs. secreted PTK7 (no TM) co-culture, p < 0.0001. All other comparisons not significant; n = 4–22 independent experiments. (C) Pre-coating wells with PTK7 NTF (aa 1–703) significantly increased cAMP levels in WT GPR133-expressing, but not H543R uncleavable mutant-expressing cells. COL6 (native purified <t>human</t> <t>collagen</t> VI) had no effect on signaling. Two-way ANOVA: GPR133 variant expressed F 2, 80 = 11.65, p < 0.0001; protein coating F 2, 80 = 12.90, p < 0.0001; interaction of factors F 4, 80 = 9.24, p < 0.0001. Tukey’s multiple comparisons: GPR133-WT-expressing cells on PTK7 NTF-coated vs. uncoated dishes, p < 0.0001; GPR133-WT-expressing cells on PTK7 NTF-coated vs. COL6-coated dishes, p < 0.0001). All other comparisons not significant; n = 5–15 independent experiments. (D) Combinatorial effect of PTK7 binding and p13 Stachel peptide treatment on GPR133 signaling. HEK293T cells expressing either WT GPR133 or empty vector control were seeded onto PTK7 NTF-coated (1.17 μg/cm 2 ) or control-coated wells. Cells were then treated with synthetic p13 Stachel peptide (500 μM), inactive control peptide (500 μM), or solvent controls, and cAMP levels were measured by HTRF. The combination of PTK7 NTF binding and Stachel peptide elicited an additive response in GPR133 signaling compared with the individual treatments. Two-way ANOVA, GPR133 expression effect F 1, 48 = 365.1, p < 0.0001; treatment effect F 7, 48 = 13.2, p < 0.0001; interaction of GPR133 expression and treatment F 7, 48 = 13.2, p < 0.0001. Tukey’s multiple comparisons: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. n = 4 independent experiments. Data are depicted as mean ± SEM. See also and .
Anti Collagen Vi Antibody, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/type+vi+collagen/AFF%2EPUR%2E+ANTI-COLLAGEN+TYPE+VI(RAB)0%2C1MG/pmc06293089-142-112-121
Average 91 stars, based on 1 article reviews
anti collagen vi antibody - by Bioz Stars, 2026-09
91/100 stars
  Buy from Supplier

93
SouthernBiotech bovine type vi collagen solution
(A) Confocal microscopic image from “sandwich cultures” shows layered cells expressing either GPR133 (green) or PTK7 (red). Top view from a central confocal slice (center panel: x and y dimension) and orthogonal views (upper panel: z and x; right panel: z and y) depicted on the same scale. Scale bars, 10 μM. (B) HTRF assays in “sandwich cultures” demonstrate that PTK7 in neighboring cells increased cAMP levels in cells expressing <t>wild-type</t> (WT) cleaved GPR133, but not the uncleavable H543R mutant. A secreted PTK7 with no transmembrane domain (no TM, aa 1–703) did not influence GPR133 signaling. Two-way ANOVA: middle layer F 2, 96 = 4.62, not significant; outer layer F 2, 96 = 3.93, not significant; interaction of inner and outer layer F 4, 96 = 7.29, p < 0.0001. Tukey’s multiple comparisons: GPR133-WT-expressing cells with empty vector vs. PTK7 co-culture, p < 0.0001; GPR133-WT-expressing cells with full-length PTK7 vs. secreted PTK7 (no TM) co-culture, p < 0.0001. All other comparisons not significant; n = 4–22 independent experiments. (C) Pre-coating wells with PTK7 NTF (aa 1–703) significantly increased cAMP levels in WT GPR133-expressing, but not H543R uncleavable mutant-expressing cells. COL6 (native purified <t>human</t> <t>collagen</t> VI) had no effect on signaling. Two-way ANOVA: GPR133 variant expressed F 2, 80 = 11.65, p < 0.0001; protein coating F 2, 80 = 12.90, p < 0.0001; interaction of factors F 4, 80 = 9.24, p < 0.0001. Tukey’s multiple comparisons: GPR133-WT-expressing cells on PTK7 NTF-coated vs. uncoated dishes, p < 0.0001; GPR133-WT-expressing cells on PTK7 NTF-coated vs. COL6-coated dishes, p < 0.0001). All other comparisons not significant; n = 5–15 independent experiments. (D) Combinatorial effect of PTK7 binding and p13 Stachel peptide treatment on GPR133 signaling. HEK293T cells expressing either WT GPR133 or empty vector control were seeded onto PTK7 NTF-coated (1.17 μg/cm 2 ) or control-coated wells. Cells were then treated with synthetic p13 Stachel peptide (500 μM), inactive control peptide (500 μM), or solvent controls, and cAMP levels were measured by HTRF. The combination of PTK7 NTF binding and Stachel peptide elicited an additive response in GPR133 signaling compared with the individual treatments. Two-way ANOVA, GPR133 expression effect F 1, 48 = 365.1, p < 0.0001; treatment effect F 7, 48 = 13.2, p < 0.0001; interaction of GPR133 expression and treatment F 7, 48 = 13.2, p < 0.0001. Tukey’s multiple comparisons: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. n = 4 independent experiments. Data are depicted as mean ± SEM. See also and .
Bovine Type Vi Collagen Solution, supplied by SouthernBiotech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/type+vi+collagen/Bovine+Type+VI+Collagen-Solution/bio_rxiv__2024__09__18__613627-216-0-4
Average 93 stars, based on 1 article reviews
bovine type vi collagen solution - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

90
Technoclone gmbh technozym® vwf:cba elisa collagen type i
(A) Confocal microscopic image from “sandwich cultures” shows layered cells expressing either GPR133 (green) or PTK7 (red). Top view from a central confocal slice (center panel: x and y dimension) and orthogonal views (upper panel: z and x; right panel: z and y) depicted on the same scale. Scale bars, 10 μM. (B) HTRF assays in “sandwich cultures” demonstrate that PTK7 in neighboring cells increased cAMP levels in cells expressing <t>wild-type</t> (WT) cleaved GPR133, but not the uncleavable H543R mutant. A secreted PTK7 with no transmembrane domain (no TM, aa 1–703) did not influence GPR133 signaling. Two-way ANOVA: middle layer F 2, 96 = 4.62, not significant; outer layer F 2, 96 = 3.93, not significant; interaction of inner and outer layer F 4, 96 = 7.29, p < 0.0001. Tukey’s multiple comparisons: GPR133-WT-expressing cells with empty vector vs. PTK7 co-culture, p < 0.0001; GPR133-WT-expressing cells with full-length PTK7 vs. secreted PTK7 (no TM) co-culture, p < 0.0001. All other comparisons not significant; n = 4–22 independent experiments. (C) Pre-coating wells with PTK7 NTF (aa 1–703) significantly increased cAMP levels in WT GPR133-expressing, but not H543R uncleavable mutant-expressing cells. COL6 (native purified <t>human</t> <t>collagen</t> VI) had no effect on signaling. Two-way ANOVA: GPR133 variant expressed F 2, 80 = 11.65, p < 0.0001; protein coating F 2, 80 = 12.90, p < 0.0001; interaction of factors F 4, 80 = 9.24, p < 0.0001. Tukey’s multiple comparisons: GPR133-WT-expressing cells on PTK7 NTF-coated vs. uncoated dishes, p < 0.0001; GPR133-WT-expressing cells on PTK7 NTF-coated vs. COL6-coated dishes, p < 0.0001). All other comparisons not significant; n = 5–15 independent experiments. (D) Combinatorial effect of PTK7 binding and p13 Stachel peptide treatment on GPR133 signaling. HEK293T cells expressing either WT GPR133 or empty vector control were seeded onto PTK7 NTF-coated (1.17 μg/cm 2 ) or control-coated wells. Cells were then treated with synthetic p13 Stachel peptide (500 μM), inactive control peptide (500 μM), or solvent controls, and cAMP levels were measured by HTRF. The combination of PTK7 NTF binding and Stachel peptide elicited an additive response in GPR133 signaling compared with the individual treatments. Two-way ANOVA, GPR133 expression effect F 1, 48 = 365.1, p < 0.0001; treatment effect F 7, 48 = 13.2, p < 0.0001; interaction of GPR133 expression and treatment F 7, 48 = 13.2, p < 0.0001. Tukey’s multiple comparisons: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. n = 4 independent experiments. Data are depicted as mean ± SEM. See also and .
Technozym® Vwf:Cba Elisa Collagen Type I, supplied by Technoclone gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/type+vi+collagen/technozym+vwf+cba+elisa+collagen+type+vi/us09581603-288-10-21
Average 90 stars, based on 1 article reviews
technozym® vwf:cba elisa collagen type i - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Gallus BioPharmaceuticals collagen, type vi, alpha vi
The source, expression, and mechanisms of exosomal noncoding RNAs in ischemic stroke.
Collagen, Type Vi, Alpha Vi, supplied by Gallus BioPharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/type+vi+collagen/collagen++type+vi++alpha+vi/pmc09406049-157-16-17
Average 90 stars, based on 1 article reviews
collagen, type vi, alpha vi - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Verlag GmbH compliany to the rigid type vi collagen lattice
The source, expression, and mechanisms of exosomal noncoding RNAs in ischemic stroke.
Compliany To The Rigid Type Vi Collagen Lattice, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/type+vi+collagen/compliany+to+the+rigid+type+vi+collagen+lattice/10__1002_slash_adtp__201900034-216-11-6
Average 90 stars, based on 1 article reviews
compliany to the rigid type vi collagen lattice - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Figure 1. The expression of Type VI collagen in oral tissues. (A) H&E staining of mandibles from 3-month-old mice. Dashed line shows periodontal ligament. (B) Representative immunofluorescent staining image of Type VI collagen in mouse mandibles of 3-month-old mice (n = 3). Magnified images of boxed areas in panel B are shown in (a’,b’,c’,d’). Nuclei were stained with DAPI (blue). Type VI collagen expression (red) in the periodontal ligament (PDL) (yellow arrowheads), bone marrow (BM) (green arrowheads), gingiva (Gn (blue arrowheads). (C) The abundance of alpha chains of Type VI collagen in murine alveolar bone from 6-week-old mice. M: molar, AB: alveolar bone, DP: dental pulp, Gn: gingiva, BM: bone marrow, PDL: periodontal ligament, Ep: epithelium, CT: connective tissue. Scale bars: (A,B): 500 µm, (a’–d’): 50 µm.

Journal: International journal of molecular sciences

Article Title: The Role of Type VI Collagen in Alveolar Bone.

doi: 10.3390/ijms232214347

Figure Lengend Snippet: Figure 1. The expression of Type VI collagen in oral tissues. (A) H&E staining of mandibles from 3-month-old mice. Dashed line shows periodontal ligament. (B) Representative immunofluorescent staining image of Type VI collagen in mouse mandibles of 3-month-old mice (n = 3). Magnified images of boxed areas in panel B are shown in (a’,b’,c’,d’). Nuclei were stained with DAPI (blue). Type VI collagen expression (red) in the periodontal ligament (PDL) (yellow arrowheads), bone marrow (BM) (green arrowheads), gingiva (Gn (blue arrowheads). (C) The abundance of alpha chains of Type VI collagen in murine alveolar bone from 6-week-old mice. M: molar, AB: alveolar bone, DP: dental pulp, Gn: gingiva, BM: bone marrow, PDL: periodontal ligament, Ep: epithelium, CT: connective tissue. Scale bars: (A,B): 500 µm, (a’–d’): 50 µm.

Article Snippet: Primary antibody specific to Type VI collagen (Fitzgerald, North Acton, MA, USA) was applied to samples at a 1:50 dilution.

Techniques: Expressing, Staining

(A) Confocal microscopic image from “sandwich cultures” shows layered cells expressing either GPR133 (green) or PTK7 (red). Top view from a central confocal slice (center panel: x and y dimension) and orthogonal views (upper panel: z and x; right panel: z and y) depicted on the same scale. Scale bars, 10 μM. (B) HTRF assays in “sandwich cultures” demonstrate that PTK7 in neighboring cells increased cAMP levels in cells expressing wild-type (WT) cleaved GPR133, but not the uncleavable H543R mutant. A secreted PTK7 with no transmembrane domain (no TM, aa 1–703) did not influence GPR133 signaling. Two-way ANOVA: middle layer F 2, 96 = 4.62, not significant; outer layer F 2, 96 = 3.93, not significant; interaction of inner and outer layer F 4, 96 = 7.29, p < 0.0001. Tukey’s multiple comparisons: GPR133-WT-expressing cells with empty vector vs. PTK7 co-culture, p < 0.0001; GPR133-WT-expressing cells with full-length PTK7 vs. secreted PTK7 (no TM) co-culture, p < 0.0001. All other comparisons not significant; n = 4–22 independent experiments. (C) Pre-coating wells with PTK7 NTF (aa 1–703) significantly increased cAMP levels in WT GPR133-expressing, but not H543R uncleavable mutant-expressing cells. COL6 (native purified human collagen VI) had no effect on signaling. Two-way ANOVA: GPR133 variant expressed F 2, 80 = 11.65, p < 0.0001; protein coating F 2, 80 = 12.90, p < 0.0001; interaction of factors F 4, 80 = 9.24, p < 0.0001. Tukey’s multiple comparisons: GPR133-WT-expressing cells on PTK7 NTF-coated vs. uncoated dishes, p < 0.0001; GPR133-WT-expressing cells on PTK7 NTF-coated vs. COL6-coated dishes, p < 0.0001). All other comparisons not significant; n = 5–15 independent experiments. (D) Combinatorial effect of PTK7 binding and p13 Stachel peptide treatment on GPR133 signaling. HEK293T cells expressing either WT GPR133 or empty vector control were seeded onto PTK7 NTF-coated (1.17 μg/cm 2 ) or control-coated wells. Cells were then treated with synthetic p13 Stachel peptide (500 μM), inactive control peptide (500 μM), or solvent controls, and cAMP levels were measured by HTRF. The combination of PTK7 NTF binding and Stachel peptide elicited an additive response in GPR133 signaling compared with the individual treatments. Two-way ANOVA, GPR133 expression effect F 1, 48 = 365.1, p < 0.0001; treatment effect F 7, 48 = 13.2, p < 0.0001; interaction of GPR133 expression and treatment F 7, 48 = 13.2, p < 0.0001. Tukey’s multiple comparisons: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. n = 4 independent experiments. Data are depicted as mean ± SEM. See also and .

Journal: Cell reports

Article Title: PTK7 is a positive allosteric modulator of GPR133 signaling in glioblastoma

doi: 10.1016/j.celrep.2023.112679

Figure Lengend Snippet: (A) Confocal microscopic image from “sandwich cultures” shows layered cells expressing either GPR133 (green) or PTK7 (red). Top view from a central confocal slice (center panel: x and y dimension) and orthogonal views (upper panel: z and x; right panel: z and y) depicted on the same scale. Scale bars, 10 μM. (B) HTRF assays in “sandwich cultures” demonstrate that PTK7 in neighboring cells increased cAMP levels in cells expressing wild-type (WT) cleaved GPR133, but not the uncleavable H543R mutant. A secreted PTK7 with no transmembrane domain (no TM, aa 1–703) did not influence GPR133 signaling. Two-way ANOVA: middle layer F 2, 96 = 4.62, not significant; outer layer F 2, 96 = 3.93, not significant; interaction of inner and outer layer F 4, 96 = 7.29, p < 0.0001. Tukey’s multiple comparisons: GPR133-WT-expressing cells with empty vector vs. PTK7 co-culture, p < 0.0001; GPR133-WT-expressing cells with full-length PTK7 vs. secreted PTK7 (no TM) co-culture, p < 0.0001. All other comparisons not significant; n = 4–22 independent experiments. (C) Pre-coating wells with PTK7 NTF (aa 1–703) significantly increased cAMP levels in WT GPR133-expressing, but not H543R uncleavable mutant-expressing cells. COL6 (native purified human collagen VI) had no effect on signaling. Two-way ANOVA: GPR133 variant expressed F 2, 80 = 11.65, p < 0.0001; protein coating F 2, 80 = 12.90, p < 0.0001; interaction of factors F 4, 80 = 9.24, p < 0.0001. Tukey’s multiple comparisons: GPR133-WT-expressing cells on PTK7 NTF-coated vs. uncoated dishes, p < 0.0001; GPR133-WT-expressing cells on PTK7 NTF-coated vs. COL6-coated dishes, p < 0.0001). All other comparisons not significant; n = 5–15 independent experiments. (D) Combinatorial effect of PTK7 binding and p13 Stachel peptide treatment on GPR133 signaling. HEK293T cells expressing either WT GPR133 or empty vector control were seeded onto PTK7 NTF-coated (1.17 μg/cm 2 ) or control-coated wells. Cells were then treated with synthetic p13 Stachel peptide (500 μM), inactive control peptide (500 μM), or solvent controls, and cAMP levels were measured by HTRF. The combination of PTK7 NTF binding and Stachel peptide elicited an additive response in GPR133 signaling compared with the individual treatments. Two-way ANOVA, GPR133 expression effect F 1, 48 = 365.1, p < 0.0001; treatment effect F 7, 48 = 13.2, p < 0.0001; interaction of GPR133 expression and treatment F 7, 48 = 13.2, p < 0.0001. Tukey’s multiple comparisons: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. n = 4 independent experiments. Data are depicted as mean ± SEM. See also and .

Article Snippet: Human Collagen Type VI , Rockland , 009-001-108.

Techniques: Expressing, Mutagenesis, Plasmid Preparation, Co-Culture Assay, Purification, Variant Assay, Binding Assay, Control, Solvent

The source, expression, and mechanisms of exosomal noncoding RNAs in ischemic stroke.

Journal: Brain Sciences

Article Title: A Novel Perspective on Ischemic Stroke: A Review of Exosome and Noncoding RNA Studies

doi: 10.3390/brainsci12081000

Figure Lengend Snippet: The source, expression, and mechanisms of exosomal noncoding RNAs in ischemic stroke.

Article Snippet: Mechanistically, ischemic neuron-derived exosomes transported CircOGDH from the penumbra tissue to peripheral blood, and then upregulated COL4A4 (Gallus collagen, type VI, alpha VI) expression with sequestering of miR-5112, resulting in neuronal apoptosis [ ].

Techniques: Expressing, RNA Expression, Activation Assay, Migration, Clinical Proteomics, Knockdown, Functional Assay